Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q9UGM5
UPID:
FETUB_HUMAN
Alternative names:
16G2; Fetuin-like protein IRL685; Gugu
Alternative UPACC:
Q9UGM5; B2RCW6; E9PG06; Q1RMZ0; Q5J876; Q6DK58; Q6GRB6; Q9Y6Z0
Background:
Fetuin-B, also known by alternative names such as 16G2, Fetuin-like protein IRL685, and Gugu, plays a crucial role in reproductive biology. It acts as a protease inhibitor essential for egg fertilization, specifically preventing premature hardening of the zona pellucida by inhibiting the protease activity of ASTL. This process is vital for ensuring successful fertilization, as it prevents the zona pellucida from becoming impenetrable to sperm.
Therapeutic significance:
Understanding the role of Fetuin-B could open doors to potential therapeutic strategies. Its critical function in preventing premature zona pellucida hardening suggests its potential in addressing fertility issues. By targeting the mechanisms by which Fetuin-B operates, new treatments for infertility could be developed, offering hope to those struggling to conceive.